213 filings
Page 7 of 11
424B5
ythkigib3ds bi
10 Mar 20
Prospectus supplement for primary offering
9:26pm
8-K
vr47rf0d4f jh
9 Mar 20
Other Events
6:05am
S-8
u99c369fquk195cfgzxf
13 Feb 20
Registration of securities for employees
12:00am
8-K
jeikii
12 Feb 20
Kala Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results
7:15am
8-K
dz9v26ugo j6vhd0
13 Jan 20
Results of Operations and Financial Condition
7:30am
8-K
9gn6ennxnxau7fbmognm
7 Nov 19
Kala Pharmaceuticals Reports Third Quarter 2019 Financial Results
7:19am
8-K
4mtxmv9pmk 46d
8 Aug 19
Kala Pharmaceuticals Receives FDA Complete Response Letter for KPI-121 0.25% NDA and Plans to Respond with Data From STRIDE 3 Trial
4:05pm
8-K
c8dhib7e
6 Aug 19
Kala Pharmaceuticals Reports Second Quarter 2019 Financial Results
7:05am
8-K
1qawpqs1yjmpj3vaffp
10 Jun 19
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
t1m9p9s
9 May 19
Kala Pharmaceuticals Reports First Quarter 2019 Financial Results
7:06am
DEFA14A
08loa
12 Apr 19
Additional proxy soliciting materials
4:08pm
S-8
1lyws8j6my06qd
12 Mar 19
Registration of securities for employees
8:42am
8-K
obteno0rv
11 Mar 19
Kala Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results
4:56pm
8-K
jb1s1r
7 Jan 19
Regulation FD Disclosure
7:00am